Reduced expression of BIRC2 and BIRC3 associated with longer survival in pediatric high-grade gliomas

No abstract is available for this paper.

• Publication year

  2026

• Venue

  Scientific Reports

• Publication date

  2026-01-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41598-026-35887-7PMID 41617829PMCID PMC12913816
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of Perinatal Factors on Gene Expression of IAPs Family and Main Factors of Pluripotency: OCT4 and SOX2 in Human Breast Milk Stem Cells—A Preliminary Report

  2023influential reference
• MiR-155-5p regulates autophagy and apoptosis of glioma cells through RICTOR

  2023cited by this paper
• Chromatin mutations in pediatric high grade gliomas

  2023cited by this paper
• BRD8 maintains glioblastoma by epigenetic reprogramming of the p53 network

  2022cited by this paper
• PD-L1/miR-155 Interplay in Pediatric High-Grade Glioma

  2022influential reference
• Cytoplasmic and Nuclear Functions of cIAP1

  2022cited by this paper
• Correction to: Livin/BIRC7 gene expression as a possible diagnostic biomarker for endometrial hyperplasia and carcinoma

  2022cited by this paper
• Evaluation of the Impact of Pregnancy-Associated Factors on the Quality of Wharton’s Jelly-Derived Stem Cells Using SOX2 Gene Expression as a Marker

  2022cited by this paper
• ILP-2: A New Bane and Therapeutic Target for Human Cancers

  2022cited by this paper
• Cellular inhibitor of apoptosis 2 (cIAP2) restricts neuroinflammation during experimental autoimmune encephalomyelitis

  2022cited by this paper
• Classification and Treatment of Pediatric Gliomas in the Molecular Era

  2021cited by this paper
• PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy

  2021cited by this paper
• The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.

  2021cited by this paper
• Targeting c-IAP1, c-IAP2, and Bcl-2 Eliminates Senescent Glioblastoma Cells Following Temozolomide Treatment

  2021cited by this paper
• Multiparametric MRI Features Predict the SYP Gene Expression in Low-Grade Glioma Patients: A Machine Learning-Based Radiomics Analysis

  2021cited by this paper
• BIRC3 and BIRC5: multi‐faceted inhibitors in cancer

  2021cited by this paper
• PD-L1 Expression Correlated with p53 Expression in Pediatric Glioblastoma Multiforme

  2021cited by this paper
• A Novel Role of BIRC3 in Stemness Reprogramming of Glioblastoma

  2021cited by this paper
• Livin/BIRC7 gene expression as a possible diagnostic biomarker for endometrial hyperplasia and carcinoma

  2021cited by this paper
• Expression of Olig2, Nestin, NogoA and AQP4 have no impact on overall survival in IDH-wildtype glioblastoma

  2020cited by this paper
• Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade.

  2020cited by this paper
• Gene expression profiling of glioblastoma cell lines depending on TP53 status after tumor-treating fields (TTFields) treatment

  2020cited by this paper
• miR-155 Regulates the Proliferation of Glioma Cells Through PI3K/AKT Signaling

  2020influential reference
• Comprehensive molecular characterization of inhibitors of apoptosis proteins (IAPs) for therapeutic targeting in cancer

  2020cited by this paper
• Increased Expression of BIRC2, BIRC3, and BIRC5 from the IAP Family in Mesenchymal Stem Cells of the Umbilical Cord Wharton's Jelly (WJSC) in Younger Women Giving Birth Naturally

  2020cited by this paper
• The RAS‐PI3K‐AKT‐NF‐κB pathway transcriptionally regulates the expression of BCL2 family and IAP family genes and inhibits apoptosis in fibrous epulis

  2019influential reference
• Inhibitor of Apoptosis Proteins Determines Glioblastoma Stem‐Like Cell Fate in an Oxygen‐Dependent Manner

  2019cited by this paper
• Importance of GFAP isoform‐specific analyses in astrocytoma

  2019cited by this paper
• Regulation of innate and adaptive antitumor immunity by IAP antagonists.

  2018cited by this paper
• Inhibitors of apoptosis: clinical implications in cancer

  2017cited by this paper
• Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma

  2017cited by this paper
• Analysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma

  2016cited by this paper
• Applications of Genomic Sequencing in Pediatric CNS Tumors.

  2016cited by this paper
• The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

  2016cited by this paper
• Pediatric high-grade glioma: biologically and clinically in need of new thinking

  2016cited by this paper
• Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.

  2016cited by this paper
• Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies

  2016cited by this paper
• PD-L1 expression and prognostic impact in glioblastoma.

  2016cited by this paper
• BIRC3 is a novel driver of therapeutic resistance in Glioblastoma

  2016cited by this paper
• Survivin and gliomas: A literature review

  2016cited by this paper
• A potential role of X-linked inhibitor of apoptosis protein in mitochondrial membrane permeabilization and its implication in cancer therapy.

  2016cited by this paper
• Expression of IAP family proteins and its clinical importance in breast cancer patients.

  2015cited by this paper
• Ki67 is a promising molecular target in the diagnosis of cancer (review).

  2015cited by this paper
• Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011.

  2015cited by this paper
• Management of high-grade gliomas in the pediatric patient: Past, present, and future.

  2014cited by this paper
• Differential expression of BIRC family genes in chronic myeloid leukaemia – BIRC3 and BIRC8 as potential new candidates to identify disease progression

  2014cited by this paper
• Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge

  2014cited by this paper
• The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma

  2014cited by this paper
• The expression BIRC6 gene in patients with chronic lymphocytic leukemia – a preliminary study

  2014cited by this paper
• The somatic genomic landscape of glioblastoma.

  2013cited by this paper
• Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

  2012cited by this paper
• The Inhibitor of Apoptosis (IAPs) in Adaptive Response to Cellular Stress

  2012cited by this paper
• Pediatric High Grade Glioma: a Review and Update on Tumor Clinical Characteristics and Biology

  2012cited by this paper
• Targeting IAP proteins for therapeutic intervention in cancer

  2012cited by this paper
• Cellular inhibitors of apoptosis proteins cIAP1 and cIAP2 are required for efficient caspase-1 activation by the inflammasome.

  2011cited by this paper
• Role of IAPs in prostate cancer progression: immunohistochemical study in normal and pathological (benign hyperplastic, prostatic intraepithelial neoplasia and cancer) human prostate

  2010cited by this paper
• Neuronal apoptosis inhibitory protein, NAIP, is an inhibitor of procaspase-9.

  2010cited by this paper
• Survivin: a promising tumor biomarker.

  2007cited by this paper
• The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization

  2007cited by this paper
• Overexpression of cellular inhibitor of apoptosis protein 2 is an early event in the progression of pancreatic cancer

  2006cited by this paper
• Detection of autoantibodies to livin and survivin in Sera from lung cancer patients.

  2005cited by this paper
• IAPs, RINGs and ubiquitylation

  2005cited by this paper
• Expression of Inhibitor-of-Apoptosis Protein (IAP) Livin by Neuroblastoma Cells: Correlation with Prognostic Factors and Outcome

  2005cited by this paper
• Inhibitor of Apoptosis Proteins: Translating Basic Knowledge into Clinical Practice

  2004cited by this paper
• Apollon ubiquitinates SMAC and caspase-9, and has an essential cytoprotection function

  2004cited by this paper
• Treatment of infants with malignant gliomas: The Pediatric Oncology Group Experience

  2004cited by this paper
• The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer.

  2004cited by this paper
• Structure and function analysis of peptide antagonists of melanoma inhibitor of apoptosis (ML-IAP).

  2003cited by this paper
• Subcellular expression of c-IAP1 and c-IAP2 in colorectal cancers: relationships with clinicopathological features and prognosis.

  2003cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern

  2001cited by this paper
• XIAP: Apoptotic brake and promising therapeutic target

  2001cited by this paper
• NMR Structure and Mutagenesis of the Third Bir Domain of the Inhibitor of Apoptosis Protein XIAP*

  2000cited by this paper
• Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma

  1999cited by this paper
• A human IAP-family gene, apollon, expressed in human brain cancer cells.

  1999cited by this paper
• Solution structure of a baculoviral inhibitor of apoptosis (IAP) repeat

  1999cited by this paper
• Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases

  1999cited by this paper
• The CARD domain: a new apoptotic signalling motif.

  1997cited by this paper
• Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes

  1996cited by this paper
• The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins.

  1995cited by this paper
• The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy.

  1995cited by this paper
• GFAP in brain tumor diagnosis: possibilities and limitations.

  1985cited by this paper

• No citing papers are available for this paper.